Prostate Cancer
Impact of androgen receptor alterations on cell-free DNA genomic profiling on survival outcomes in metastatic castration-resistant prostate cancer.
September 1, 2023
Trends in prostate cancer screening in the pre- and peri-COVID-19 Pandemic period.
September 1, 2023
Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy.
September 1, 2023
A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.
September 1, 2023
Targeting MerTK decreases efferocytosis and increases anti-tumor immune infiltrate in prostate cancer.
August 31, 2023
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.
August 30, 2023
Preclinical Evaluation of a New Series of Albumin-Binding 177Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics.
August 30, 2023
A randomised trial of [18F]PSMA-1007-PET/CT versus NaF-PET/CT for staging primary prostate cancer: A trial protocol.
August 29, 2023